Search

everythinglearnresearchcommunity

for

Search:↓

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

Men need higher doses of botox than women and a different approach for facial aesthetics due to their unique facial features and muscle mass.

PCOS significantly affects women's mental health, and more research is needed to develop effective treatments for these issues.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

Finasteride users with sexual issues often experience depression.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

The conclusion is that more women in their forties are getting AGA and stress is linked to AGA in both men and women.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

Finasteride is linked to sexual dysfunction, especially in younger men using it for hair loss.

Cervi Parvum Cornu complex improved urinary symptoms in men without major side effects.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

Testosterone therapy had limited benefits for a man with depression and suspected low testosterone, highlighting the need for careful diagnosis and treatment planning.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

Finasteride use can cause lasting negative effects like sexual dysfunction, depression, anxiety, and cognitive issues.

Trichodynia found in 29% of TE or AGA patients, linked to psychological conditions.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Addressing body image and weight can help improve female sexual dysfunction.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.